| [1] | SIEGEL R L, MILLER K D, JEMAL A. Cancer statistics, 2019[J]. CA Cancer J Clin,2019,69(1):7-34 |
| [2] | 郑保良, 孙国庆. 激素敏感转移性前列腺癌的临床预后因素研究[J]. 实用癌症杂志, 2018, 33(6):995-997, 1017 |
| [3] | DEN R B, GEORGE D, PIECZONKA C, et al. Ra-223 treatment for bone metastases in castrate-resistant prostate cancer: practical management issues for patient selection[J]. Am J Clin Oncol,2019,42(4):399-406 |
| [4] | EL-AMM J, ARAGON-CHING J B. The changing landscape in the treatment of metastatic castration-resistant prostate cancer[J]. Ther Adv Med Oncol,2013,5(1):25-40 |
| [5] | WU X, DING B Y, GAO J, et al. Second-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapy[J]. Int J Nanomedicine,2011,6:1747-1756 |
| [6] | WILNER S E, WENGERTER B, MAIER K, et al. An RNA alternative to human transferrin: a new tool for targeting human cells[J]. Mol Ther Nucleic Acids,2012,1:e21 |
| [7] | KELLY J M, AMOR-COARASA A, PONNALA S, et al. Albumin-binding PSMA ligands: implications for expanding the therapeutic window[J]. J Nucl Med,2019,60(5):656-663 |
| [8] | HINSON D L, WEBBER R J. Miniaturization of the BCA protein assay[J]. BioTechniques,1988,6(1):14, 16, 19 |
| [9] | NI X, CASTANARES M, MUKHERJEE A, et al. Nucleic acid aptamers: clinical applications and promising new horizons[J]. Curr Med Chem,2011,18(27):4206-4214 |
| [10] | CHANG Y M, DONOVAN M J, TAN W H. Using aptamers for cancer biomarker discovery[J]. J Nucleic Acids,2013,2013:817350 |
| [11] | CHUNG C H, KIM J H, JUNG J, et al. Nuclease-resistant DNA aptamer on gold nanoparticles for the simultaneous detection of Pb2+ and Hg2+ in human serum[J]. Biosens Bioelectron,2013,41:827-832 |
| [12] | HUANG Y Z, HERNANDEZ F J, GU B, et al. RNA aptamer-based functional ligands of the neurotrophin receptor, TrkB[J]. Mol Pharmacol,2012,82(4):623-635 |
| [13] | SUNDARAM P, KURNIAWAN H, BYRNE M E, et al. Therapeutic RNA aptamers in clinical trials[J]. Eur J Pharm Sci,2013,48(1-2):259-271 |
| [14] | PALMERSTON MENDES L, PAN J Y, TORCHILIN V P. Dendrimers as nanocarriers for nucleic acid and drug delivery in cancer therapy[J]. Molecules,2017,22(9):E1401 |
| [15] | LU Y, JIANG W J, WU X, et al. Peptide T7-modified polypeptide with disulfide bonds for targeted delivery of plasmid DNA for gene therapy of prostate cancer[J]. Int J Nanomedicine,2018,13:6913-6927 |